Haemonetics Corp. (HAE) Misses Q4 EPS by 3c; Guides FY13 EPS Below Views
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $89.58 -1.34%
Financial Fact:
Selling, general and administrative: 71.12M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Selling, general and administrative: 71.12M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Haemonetics Corp. (NYSE: HAE) reported Q4 EPS of $0.80, $0.03 worse than the analyst estimate of $0.83. Revenue for the quarter came in at $186.7 million versus the consensus estimate of $183.09 million.
Haemonetics Corp. sees FY2013 EPS of $3.30-$3.40, versus the consensus of $3.50.
For earnings history and earnings-related data on Haemonetics Corp. (HAE) click here.
Haemonetics Corp. sees FY2013 EPS of $3.30-$3.40, versus the consensus of $3.50.
For earnings history and earnings-related data on Haemonetics Corp. (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- DA Davidson Reiterates Buy Rating on Boost Run (BRUN)
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
